Oak Ridge, TN, August 1, 2007 - Clean Air Labs, LLC announced that it has been granted a license by the United States Environmental Protection Agency (U.S. EPA) to a DNA-based technology used to identify and quantify over 130 major indoor air molds. 

The EPA's patented technology for mold analysis is far superior to all currently available commercial mold analysis. Clean Air Labs joins 15 other groups worldwide holding the license.

Common spore trap analysis can't compete with Real-Time PCR in terms of accuracy and quantification, said Dr. Edward Sobek, Chief Scientific Officer of Clean Air Labs. As such, we are utilizing EPA's technology coupled with Real-Time PCR to further advance the development of mold DNA analysis in the indoor air quality industry. In addition to becoming licensed by the EPA, Clean Air Labs has bolstered its equipment holdings, enabling it to conduct such analysis. 

DNA mold detection offers much more than conventional analysis in terms of results. The EPA has developed over 130 DNA sequences for important indoor air molds. With DNA, it is possible to draw from the body of scientific literature of mold ecology to make inferences about the status of a particular indoor air environment. Moreover, the EPA has identified groups of molds associated with increased asthma rates and upper respiratory problems, compiled the data into database known as ERMI. Clean Air Labs intends to probe samples for a variety of health-impact molds, furthering research and market applicability of the Real-Time PCR DNA analysis. 

Clean Air Labs is a member of The Chiodo Companies, Inc., a diversified family of companies, with interests in biotechnology, indoor air quality and infrared thermography services. 

For more information, visit www.cleanairlabs.com or contact Vojkan Dimitrijevic at vojkand@cleanairlabs.com.